Author: John

on

As a Nationwide Third Party Administrator (TPA), we receive numerous inquiries on the topic of random drug testing. Oftentimes random is referred to as “spot,” drug testing and it is a strong deterrent to drug users because it is conducted on an unannounced basis.

Employers should also have a drug free workplace policy which out lines the who, what, where, when, why and how of their drug testing program.

What is the best method for random testing?

Our best recommendation for a random drug testing program is to utilize a random selection process where everyone has an equal chance of being selected for the random test.  Some examples include: using a random-number table or a computer-based random number generator that’s traceable to a specific employee. The most important factor is to be sure to use a scientifically valid method to select employees for testing.

Employers who utilize a computerized random selection process will ensure that there is no bias and that all employees have an equal chance of being selected, regardless if individuals have been drug tested recently.

Implementing a random drug testing program may be a more effective method to detect and deter drug use in conjunction with pre-employment testing because employees are uncertain as to when they may be selected for testing.

Typically, most drug free workplace policies do not even outline the basics of a properly written policy and we find that many employers believe that merely having a statement that they are a drug free workplace is the policy.
It is important to be aware that a statement in your handbook does not constitute a policy and in fact, it may be opening your business/organization to potential liability.

How does the computerized method work?

Every employer can outline the parameters of their random drug testing program based on their specific drug free workplace policy. Their policy should set the number of employees to be tested and the frequency of such testing.

Privately owned non -regulated businesses can make that determination on a case by case basis. However, regulated companies such as those covered by CFR 49 part 40 must adhere to strict requirements regarding their random drug testing program. Below are the current random testing rates for businesses/individuals regulated or “covered” under CFR 49 Part 40.

The following chart outlines the annual minimum drug and alcohol random testing rates established within DOT Agencies and the USCG for 2018.
DOT Agency 2018 Random Drug Testing Rate 2018 Random Alcohol Testing Rates

The following chart outlines the annual minimum drug and alcohol random testing rates established within DOT Agencies and the USCG for 2018.
DOT Agency 2018 Random Drug Testing Rate 2018 Random Alcohol Testing Rate
Federal Motor Carrier Safety Administration
[FMCSA]		 25% 10%
Federal Aviation Administration
[FAA]		 25% 10%
Federal Railroad Administration
[FRA]		 25% – Covered Service 10% – Covered Service
50% – Maintenance of Way * 25% – Maintenance of Way *
Federal Transit Administration
[FTA]		 25% 10%
Pipeline & Hazardous Materials Safety Administration
[PHMSA]		 50% N/A
United States Coast Guard

[USCG]

(now with the Dept. of Homeland Security

 25% N/A

Why Random Drug Testing

With today’s climate regarding drug use and abuse, there is a high probability of drug use occurring and by implementing a drug free workplace policy that is comprehensive and includes both pre-employment and random drug testing will help reduce the number of employees working at your company that are doing illegal drugs.
This will translate into less accidents, sick days, better productivity, and a safer work environment for both employees and customers.

Ensuring Employee Safety

Some occupations are dangerous to perform even when person is not impaired. Employees using heavy equipment, or operating machinery that requires an employee to be alert and not under the influence. Pre-employment urine drug testing typically provides a detection window of approximately 3-5 days; therefore, an individual seeking employment may stop using just to get the job and start right back up again.
Random drug testing will help deter use and that the employee doesn’t work while under the influence, protecting themselves, other staff and the public from potential accidents.

Employers having both pre-employment and a random drug testing program can assist your organization to stand out with respect to safety. In general, people want to feel safe and they want an organization to be reliable, consistent and provide clear and concise standards. Implementing a random testing program may help demonstrate that you invested in employee safety and your customer’s safety and satisfaction. Furthermore, it can also help you attract higher quality candidates leading to better job satisfaction, higher morale and increased productivity.

For more information on random drug testing call us today at 800-221-4291

 

on

 

This Saturday April 28, 2018 the DEA will be hosting its’ annual National Prescription Drug Take Back Day.  This important day is a vital factor which addresses a crucial public safety and public health issue. Drug use, abuse and deaths associated with the National Opioids epidemic has reached an all time high.

In 2015 there was a National survey on drug use and health, which estimated that 6.4 million Americans abused controlled prescription drugs.

The data reported in the study illustrated that a significant portion of the abused prescription drugs were obtained from family, friends and often from someone’s home medicine cabinet.

How Did The Prescription Take Back Day Begin?

On September 8, 2014, the Drug Enforcement Administration (DEA) issued a final rule available to the general public.  This final rule discussed the disposal of pharmaceutical controlled substances.  Click here for a summary of the Disposal Act.

The Disposal Act amended the Controlled Substances Act (CSA).  This amendment allowed the DEA the authority to disseminate the new regulations, within the framework of the CSA.  This will allow ultimate users to turn in any unused pharmaceutical or any controlled substances to appropriate locations for disposal in a safe and effective manner that would not negatively impact the environment and help secure any further unauthorized access to these substances. The purpose of the Disposal Act is to help support public and private entities to create a variety of methods of collection and disposal in a secure, convenient, and responsible manner.

Click here to locate a collection site near you  or call 800-882-9539

The DEA’s Take Back Day events provide an opportunity for Americans to prevent drug addiction and overdose deaths.

on

 

How Long Will My Drug Test Results Take?

Many of our customers, clients, and industry partners ask us about the typical life or process of a drug test.  There are several factors that play a role in the cycle of a drug test, from collection, to analysis, and then issuance of the final result.

When a donor provides a specimen, the specimen begins on a journey of specific steps in a streamlined and systematic process to provide a consistent and reliable result.

All of our collection personnel are professionally trained and certified to ensure that they provide a positive experience for an individual submitting for a drug test.  This process is used in conjunction with our SAMHSA Certified laboratory teams that execute the highest standards of quality control and analysis on all specimens.

What are factors that relate to Drug Test Turnaround Times?

Turnaround time is a frequently used term to measure the length of time it takes to return a positive or negative drug test result to the employer or individual. We feel that it is an important concept to understand and should be used as one of the factors when you are selecting a drug testing provider and Laboratory.  We understand that as an employer, as you attempt to hire new candidates and get current employees back to work as quickly as possible is of the up most importance.

Our Laboratories measure turnaround time at 3 major time stamps throughout the process and we pride ourselves in keeping you informed of factors that could impact the drug testing process.

The Collection Site

Prior to the specimen reaching the lab, the collection site plays a role as the first step in the specimen life cycle.  Our collectors are trained to follow a strict standardized process at every location to help ensure the integrity of the collection process, specimens and the drug test results.

Our provider network has thousands of collection sites that are electronically enabled, which allows the collectors to begin, process and complete drug test collections using an electronic chain of custody form (eCCF).  This electronic CCF saves paper, generates more accurate time stamps and prevents human errors that could occur with the standard 5-part carbon copy CCF.

Logistics

Once the donor has provided their specimen, the collection site arranges for the specimen to be picked up and transported directly to the Lab for processing.  Logistics plays a role in the turnaround time equation.  Some examples include the time the collection takes place (end of business day or after normal pick up time), day of the week the collection occurred, weather, and Holidays are just to name a few.

We understand that speed can be a critical component of a workplace drug testing program and we strive to provide the most efficient, accurate and streamlined process to exceed all our clients’ needs.

For more information on setting up an employer account or to learn more about becoming a drug free workplace click or call today 1-800-221-4291.

What happens when the Specimen Reaches the Lab?

Arrival

  • Drug Testing specimens reach our laboratories though many different couriers and modes of transportation
  • Once they arrive at the unloading dock, they are considered “received” and enter processing.
  • Once the specimens are received,they are removed from their packaging, sorted by specimen type, and transitioned to the laboratory floor.

Testing Process

  • Entering the laboratory, specimens are accessioned into the laboratory management system.
  • All specimens go through an initial screening process which varies by specimen type
  • If the screening results are negative no further testing is needed
  • If the Initial screening indicates a presumptive positive (non-negative), the specimen will undergo further confirmation testing.

Result Reporting

  • All of our lab results whether they are negative or non-negative are sent to our in-house  Medical Review Officers (MRO), who analyze the results before releasing the final result.

The life cycle of a drug testing specimen can be filled with many twists and turns.  Here at Accredited Drug Testing, Inc., we pride ourselves on providing timely accurate results which is always the highest priority for our customers. It is important to remember that there are many factors contributing to the turnaround time of specimens.

What Is The Turn Around Time For A Urine Drug Test?

 The Laboratory conducts a two-tiered testing/confirmation process at the laboratory which is described as the initial screen and confirmation testing process.  Negative screening results are typically released with 24 hours and non-negative screens are typically released within an additional 24-72 hours.

What Is The Turn Around Time For a Hair Drug Test?

The Laboratory conducts a two-tiered testing/confirmation process at the laboratory which is described as the initial screen and confirmation testing process. Negative Screening Results are typically released within 48 hours and non-negative results requiring confirmation testing are typically released within an additional 48-72 hours.

Schedule Drug, Alcohol, DNA Tests

For more information on our drug testing process, turnaround times or to schedule a test call us today at (800)-221-4291

on

 

The United States Coast Guard has announced today that the minimum random drug testing rate for all “Covered” employees will remain at 25% effective January 1, 2018 through December 31, 2018.  It is also important to note that call employers must submit their 2017 Management Information Systems (MIS) reports on or before March 15, 2018.  Click here for the entire USCG announcement.

The USCG stated that annual MIS reports may be submitted electronically to the following email address:  DAPI@uscg.mil

Are your DOT Policies Up To Date?

With the announcement of random drug testing rate, employers should take this time to review their current DOT Policy to ensure compliance with with the new rule effective January 1, 2018.

The DOT rule changed addressed the changes to the DOT Agencies & United States Coast Guard (USCG) in regard to DOT-regulated employers what updates their DOT policies will need to contain as it relates to the changes to 49 CFR Part 40.

What Is The “New” DOT 5 Panel?

The DOT has amended its current rule to include the following substances in the 5 panel DOT Drug Test.  As specified in DOT regulations 49 CFR part 40 with the Cut Off levels listed in DOT regulations 49 CFR part 40; the following substances will be tested for:

  1. Marijuana metabolites
  2. Cocaine metabolites
  3. Phencyclidine
  4. Opioids** – codeine, heroin, morphine, oxycodone, oxymorphone, hydrocodone & hydromorphone
  5. Amphetamines -amphetamine, methamphetamine, MDMA & MDA

**Some common names for the new semi-synthetic opioids include OxyContin®, Percodan®, Percocet®, Vicodin®, Lortab®, Norco®, Dilaudid®, and Exalgo®.

For more information on policy Development, Addendum to your current policy or to enroll in a Random DOT Drug and Alcohol Testing Pool (Consortium), please call Accredited Drug Testing, Inc. at 800-221-4291 or click here to enroll online

 

 

on

What is Ketamine

Ketamine is categorized as a dissociative anesthetic. A dissociative anesthetic is a drug that distorts perception of sight and sound and produces feelings of detachment or dissociation from the environment and self. On the streets, the drug is sold as either a colorless, odorless liquid or as a white or off-white powder.

History Of Ketamine

Image result for ketamine

Ketamine was developed in the 1960s to replace phencyclidine (PCP) as an anesthetic agent.  Most of the time, it is used in veterinary medicine as an animal tranquilizer, although also may be used in human medicine as an anesthetic. Used improperly, on the streets, the drug is often injected, consumed in drinks, snorted, or added to joints or cigarettes. Ketamine was placed on the list of controlled substances in the US in 1999.

Teens are Primary Users

ketamine

One of the most alarming facts about Ketamine is the primary age group of abusers is between the ages of 12 and 25 years old. According to the Drug Abuse Warning Network, individuals aged 12 to 25 accounted for 74 percent of the Ketamine emergency department mentions in the United States in 2000. Use among high school students is a growing concern. Nearly 3 percent of high school seniors in the United States used the drug at least once in the past year.

A Club Drug

In addition to Rohypnol and GHB, Ketamine is also considered a “club drug”, or “date rape drug” and may be used in drug-facilitated sexual assault situations.
Adults sometimes place the drug in the drink of an unsuspecting user and await the effects of the drug to take place. Once the individual is under the influence, there are risks of amnesia and blackout.

Effects Of Ketamine

Ketamine is a very dangerous drug and even using it a single time can have serious repercussions including the potential for long-term side-effects, coma or death. According to the National Institute on DruImage result for ketamine drug statsg Abuse, “Ketamine distorts perceptions of sight and sound and produces feelings of detachment from the environment and self.” At low doses, users can experience impaired attention, learning ability and memory. In higher doses, it can cause dreamlike states, hallucinations, delirium, unconsciousness, and flashbacks-reoccurrences of a certain aspect of the drug experience at any time. Other associated side effects are depression, delirium, amnesia, impaired motor function, high blood pressure, and potentially fatal respiratory problems.

Street Names

The most popular name used for ketamine in the streets is “Special K”. There are also many other common street names that refer to this drug.

  • K
  • Cat Valium
  • Super C
  • Green

Ketamine street names that are brand or type-specific include:

  • Ketaset
  • Ketalar
  • Ketalar SV
  • Ketanest
  • Ketanest S

Drug Testing For Ketamine

As with testing for any other drug, there are specific procedures for Ketamine drug testing. Ketamine is not included in a 5-panel drug screen. The only way Ketamine use can be detected is by studying the levels of “Norketamine” in the blood and urine. The parent drug, Norketamine is detectable in the blood and urine of users for up to 7-14 days depending on dosage and frequency of use. In some cases involving regular users, Ketamine can be detected in a drug screen beyond the typical 7-14 day period.

on

What is DATIA?
DATIA

DATIA: Drug and Alcohol Testing Industry Association.

The Drug and Alcohol Testing Industry Association (DATIA) was founded in 1995 and has grown to represent over 1500 member companies, and expanded its scope. DATIA now represents the entire spectrum of drug and alcohol service providers including collection sites, laboratories, consortiums/TPAs, MROs, and testing equipment manufacturers.

The Accredited Collection Facility Program, administered by the Drug & Alcohol Testing Industry Association (DATIA), created by leaders in the drug and alcohol testing industry interested in raising the level of accuracy in urine specimen collections.

This enables collection facilities to assure their clients that they are committed to offering superior collection services.

For some entities, like those regulated under DOT Part 40, its employees must be drug tested by a company with DATIA Certifications.

Drug & Alcohol Testing Industry Association (DATIA) Mission and Purpose

  • Promote the highest possible standards of professionalism, quality control in the drug and alcohol testing industry, and develop and oversee education, certification, and accreditation programs for the drug and alcohol testing industry
  • Serve as the voice for the industry on regulatory and legislative matters of drug and alcohol testing, collection issues as well as drug-free workplace regulatory issues
  • Serve as a body for discussion and resolution of common problems and issues affecting the drug and alcohol testing industry;
  • Inform its members of issues affecting their businesses through newsletters, legislative alerts, and meetings;
  • Collect and disseminate information on drug and alcohol service and product providers through a national directory distributed to business and the general public; and,
  • Actively cooperate with other entities, organizations, and service providers involved with or affected by drug and alcohol testing on common interests and values

The Accredited Collection Facility Program involves upholding the highest professional standards in the following two main areas:

(1)the collection facility and its operation and
(2)the collection facility’s personnel.

To obtain accredited status, collection facilities are required to adhere to strict standards in areas such as:

  • Regulatory compliance
  • Company services standards
  • Specimen handling
  • Operational practices
  • Business ethics
  • Facility equipmentAll accredited collection facilities are also required to maintain a staff of Certified Professional Collectors that are formally trained in DATIA’s Collector Training Course or that received training from the CPCT on their staff and successfully completed the DATIA Certification Exam.

What Is A SAMHSA Certified Lab?

SAMHSA: The Substance Abuse Mental Health Services Administration

Formerly known as NIDA, National Institute of Drug Abuse, SAMHSA is a Federal department of Government which regulates and certifies laboratories drug testing specimens. Currently, SAMHSA regulated laboratories are the only type of labs that may process any employee who is governed by the United States Department of Transportation (DOT).

SAMHSA Policies

SAMHSA Laboratory Certification is the highest standard available for drug testing labs and ensures the most accurate processing. Through SAMHSA all non-negative, and positive donor specimens are tested.

The Lab will conduct specimen validity tests (SVTs) to determine if the specimen was adulterated or substituted. Tests found to be adulterated or substituted are also reported to the MRO and may be considered a refusal to test.

At the laboratory, the staff will determine if a flaw in the specimen exists.If a flaw exists, the specimen is rejected for testing.

If no flaw exists, this is the process that a specimen will undergo under SAMHSA Guidelines.

  1. Open only the A bottle and conduct a screening test.
  2. Specimens that screen positive will be analyzed again using a completely different testing methodology.
  3. If the specimen tests negative in either test, the result will be reported as a negative.
  4. Only if the specimen tests positive under both methods will the specimen be reported to the medical review officer as a positive test.
  5. Report the findings of the analysis of the A bottle to the Medical Review Officer (MRO)
  6. Store the A and B bottles for any reported positive, adulterated, or substituted result for at least 12 months.

Accredited Drug Testing Certifications

SAMHSA Certified

Accredited Drug Testing Is DATIA Certified, and has also been recognized as Nationally Accredited though DATIA. There are only 25 drug testing facilities that have been rewarded this privilege.

Accredited Drug Testing only utilizes SAMSHA Certified Laboratories.

At Accredited Drug testing, we hold our company to the highest values in the Drug Testing Industry to provide our clients this the best services.

“When you need a test, chose the best”!

on

IMPORTANT NOTICE!

Effective January 1, 2018, The Department of Transportation is amending its drug-testing program regulation to add hydrocodone, hydromorphone, oxymorphone, and oxycodone to its drug-testing panel. The revision of the drug-testing panel harmonizes DOT regulations.
See below for more information.

2017, What A Year! – Our Thanks!
 
As 2017 comes to a close, Accredited Drug Testing Inc and our affiliated companies wish to thank our clients, industry partners, and employees for making this year a tremendous success. With the expansion of our corporate offices, additional staff, new services, and more testing centers throughout the nation, Accredited Drug Testing is ready to serve all our clients drug, alcohol, and DNA testing needs in 2018!   
 

Service Spotlight

Occupational Health Testing

Drop image here

Accredited Drug Testing, Inc. offers Occupational Health Testing.  Services range from  Audio-grams, Blood Collections, Body Metric Screenings, EKG, Physicals (DOT & NON-DOT), Respirator Certification and much more.
 
For more information regarding Occupational Health Testing Services 
please call 800-221-4291.
 

Industry News

Stay up-to-date with all industry news including new drug laws, policy changes, and drug epidemics by visiting our blog.

James A. Greer, President and CEO of Accredited Drug Testing and Vice President John Burgos attended The IFDAT conference this year to stay up to date with leading industry news. Allowing Accredited Drug Testing to better serve you! 
 
What is IFDAT?
 
The International Forum for Drugs and Alcohol Testing (IFDAT) is an annual event where drug testing and related industry professionals come together. Experts from all over the world unite to share their knowledge with the rest of the international community.

Drop image here

Attorney General Sessions & DEA Patterson Fight Against Opioid Crisis   
Attorney General Sessions and Acting DEA Administrator Patterson announce new efforts being made by the United States Government to follow through with the fight against the deadly Opioid Crisis in America.
On Wednesday, November 29th, 2017,  at a press release held in Washington.
 
Read More…
President Donald Trump Declares Opioid Crisis A Public Health Emergency

64,000 Americans died from overdoses last year — 175 every day, seven every hour.
These are real-life statistics of the effects the opioid epidemic has had on the American population.
On Thursday, October 26th, President Trump declared the opioid crisis as a public health emergency.
Read More…

DOT Corner

Drop image here

DOT Amends Drug-Testing Regulations
 
On November 13th, 2017 The United States Department Of Transportation, DOT, published its final rule regarding DOT drug and alcohol policy.
The DOT compliant drug screening will expand its current 5-panel urine test, to include expanded testing on Opiates, including Hydromorphone, Oxymorphone, and Oxycodone.
Effective January 1st, 2018 a DOT urine drug analysis will test for
 
Amphetamines
Cocaine
Marijuana
MDA
PCP
Opiates
Hydromorphone
Oxymorphone
Oxycodone
 
The opiates category of a 5-panel drug screen tests for the illicit drug heroin, and the licit drugs codeine and morphine.
DOT Part 40 Amendment – Final Rule
On November 13th, 2017 The United States Department Of Transportation, DOT, published its final rule regarding DOT drug and alcohol policy.
The DOT compliant drug screening will expand its current 5-panel urine test, to include expanded testing on Opiates
Read More…
Preparing For Impacts of the DOT Part 40 Final Rule
On January 1st, 2018, the revised CFR 49 Part 40 Final rule, published November 13th, 2017, will be put into effect. This rule refers to the Drug and Alcohol testing procedures and programs to all safety-sensitive employees regulated by the U.S Department Of 
Transportation (DOT). 
Read More…
Accredited Drug Testing values our clients and industry partners.   
Thank you for choosing Accredited Drug Testing for all your drug testing needs! 
 
ADT STATISTICS
November

3712 Tests
Scheduled/Performed

Proud To Serve Over
857 Employers Nationwide

38 New Clients 
Welcome!

 

The process to schedule a drug, alcohol, or any service at any testing center nationwide is fast and easy. There are three different methods which you may utilize depending on the method you prefer.

Method 1: Call Our National Scheduling Office at 800-221-4291

Method 2: Email orders@accrediteddrugtesting.net

Method 3: Receive Login to Scheduling System (Brief Training Required)

on

Cannabinoid hyperemesis syndrome, a new illness only recently acknowledged by the medical community has been seen more commonly since new states have been legalizing medical and recreational marijuana.

medical marijuana

It affects a small population — mostly, a subset of marijuana users who smoke multiple times a day for months, years or even decades.

Cannabinoid Hyperemesis Syndrome is characterized by cyclic episodes of nausea and vomiting and frequent hot bathing. Image result for cannabinoid hyperemesis syndrome

Chalfonte LeNee Queen suffered periodic episodes of violent retching and abdominal pain that would knock her off her feet for days, sometimes leaving her writhing on the floor in pain.

“I’ve screamed out for death,” says Queen, 48, who lives in San Diego. “I’ve cried out for my mom, who’s been dead for 20 years, mentally not realizing she can’t come to me.”

Diagnosing Cannabinoid Hyperemesis Syndrome can be frustrating and expensive.

There is no blood test to link the stomach ailment with marijuana use, so physicians often order pricey CT scans and lab tests to rule out other medical problems.

One way doctors have been diagnosing the illness is when a patient says that hot baths subside the symptoms. For whatever reason, unknown, patients who develop this disease find a significant relief in hot showers and baths. Toxicologists say the heat may distract the brain from pain receptors in the abdomen but, like  Cannabinoid hyperemesis syndrome itself, is still very misunderstood.

cannabinoid hyperemesis syndrome

The exact cause and onset of  Cannabinoid hyperemesis syndrome remain much of a mystery today in the medical field. The first diagnosis of this illness can be dated back to 2004 by an Australian doctor.  Since  Cannabinoid hyperemesis syndrome is a newly recognized illness, only been seen more commonly throughout the US due to the recent passings of Marijuana laws, it is often mistaken for something else.

Toxicologists say the chemical compounds in marijuana may throw off the normal function of the body’s cannabinoid receptors, which help regulate the nervous system. Some people may be genetically predisposed to the syndrome, or marijuana’s potency or chemical makeup may have changed over time, says Dr. Craig Smollin, medical director of the San Francisco division of the California Poison Control System and an ER doctor at Zuckerberg San Francisco General Hospital.

endocannabinoid system

Since most people, especially cancer patients are told that marijuana is known to aid in nausea and vomiting, it seems hard for a patient to believe that the link to their aggressive and chronic vomiting spells is due to marijuana.  19-year-old student Cameron Nicole Beard, of East Moline, Ill., said she struggled to believe her doctors about the link between pot and severe vomiting.

“Who wants to be told you can’t smoke marijuana when you think marijuana can help?” says Beard, while recovering from a marijuana-related vomiting episode at a University of Iowa hospital in Iowa City, Iowa, last month. She said she had lost 20 pounds in 10 days.

There is still no direct cure for Cannabinoid hyperemesis syndrome, although doctors are getting better at treating the symptoms. They have been using old anti-psychotic medications and cream for muscle aches.

For questions on detecting marijuana use, please visit Accredited Drug Testing, or call 1-800-221-4291.

 

on

On November 13th, 2017 The United States Department Of Transportation, DOT, published its final rule regarding DOT drug and alcohol policy.

The DOT compliant drug screening will expand its current 5-panel urine test, to include expanded testing on Opiates, including Hydromorphone, Oxymorphone, and Oxycodone.

Effective January 1st, 2018 a DOT urine drug analysis will test for

  • Amphetamines
  • Cocaine
  • Marijuana
  • MDA
  • PCP
  • Opiates
    • Hydromorphone
    • Oxymorphone
    • Oxycodone

The opiates category of a 5-panel drug screen tests for the illicit drug heroin, and the licit drugs codeine and morphine.

Please be advised, due to the addition of the number of drugs being tested, a small price increase on  DOT drug tests will take effect.

Our labs, Medical Review Officers, and CEO will review this new panel and provide additional information as it becomes available.

Accredited Drug Testing will add an amendment in its policy regarding these changes, effective January 1st, 2018.

Things to remember

1. Blind specimen testing is no longer required.
Blind specimen testing is a specimen submitted to a laboratory for quality control testing purposes, with a fictitious identifier, so that the laboratory cannot distinguish it from an employee specimen.

2.CCF forms
You should not order new CCF forms– the current CCF forms are valid until June 30th, 2018. If you have not yet done so, now would be a good time to look into eCCF forms ( Electronic CCF). Doing this will save you time and save you the hassle of shipping and storing paperwork.

For any other questions regarding DOT Compliance – please email info@accrediteddrugtesting.net, or reach us directly at (800)221-4291.

accredited drug testing